2010-08-19
Dutasteride and prostate cancer
Publication
Publication
New England Journal of Medicine , Volume 363 - Issue 8 p. 793- 794
Additional Metadata | |
---|---|
aged, azasteroid, biopsy, blood, cancer diagnosis, cancer prevention, clinical practice, drug antagonism, dutasteride, enzyme inhibitor, human, letter, male, middle aged, note, pathology, prediction and forecasting, priority journal, prostate, prostate biopsy, prostate cancer, prostate hypertrophy, prostate specific antigen, prostate tumor, steroid 5alpha reductase | |
dx.doi.org/10.1056/NEJMc1005498, hdl.handle.net/1765/20966 | |
New England Journal of Medicine | |
Organisation | Erasmus MC: University Medical Center Rotterdam |
Schröder, F.H, & Roobol-Bouts, M.J. (2010). Dutasteride and prostate cancer. New England Journal of Medicine, 363(8), 793–794. doi:10.1056/NEJMc1005498
|